Tandem Diabetes Care Stock News

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) EVP Susan Morrison sold 34,624 shares of the companys stock in a transaction that occurred on Tuesday, November 16th. The shares were sold at an average price of $142.21, for a total value of $4,923,879.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which []

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Tandem Diabetes (TNDM) reports better-than-expected revenues for third-quarter 2021 as strong domestic and international pump shipments drive the top line.

Tandem Diabetes Care Inc (NASDAQ: TNDM) reported Q3 sales of $179.6 million, +45% Y/Y, beating the consensus of $171.41 million. The Company posted EPS of $0.09, a turnaround from a loss of $(0.15)

Tandem Diabetes Care, Inc. (TNDM) CEO John Sheridan on Q3 2021 Results - Earnings Call Transcript

Tandem Diabetes Care (NASDAQ:TNDM) reported its Q3 earnings results on Wednesday, November 3, 2021 at 04:05 PM. Here's what investors need to know about the announcement.

Tandem Diabetes Care (NASDAQ:TNDM) is set to give its latest quarterly earnings report on Wednesday, 2021-11-03. Here's what investors need to know before the announcement.

Investors are optimistic about Tandem Diabetes (TNDM) owing to robust international pump shipments and product launches.

SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2021 results after the f

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Continued adoption of Tandem Diabetes' (TNDM) t:slim X2 insulin pumps by both new and existing users is encouraging.

The stock is being added to the S&P MidCap 400 Index.

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a compan

Continued adoption of Tandem Diabetes' (TNDM) t:slim X2 technology and international expansion of the Control-IQ technology add to the company's solid second-quarter performance.

Tandem Diabetes Care's (TNDM) CEO John Sheridan on Q2 2021 Results - Earnings Call Transcript